EUVIMEDEUVIMED entdecken
Crossref

Endocrine-related adverse events associated with targeted treatment and immune checkpoint blockage in hematological malignancies

Małgorzata Bobrowicz, Magdalena Góralska, Aleksandra Kusowska, Anna Skowrońska-Szcześniak, Tomasz Bednarczuk

Hematology in Clinical Practice · 2023

DOI: 10.5603/hcp.2023.0003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology in Clinical Practice, 2023. Verfasst von Małgorzata Bobrowicz und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bobrowicz, M., Góralska, M., Kusowska, A., Skowrońska-Szcześniak, A., & Bednarczuk, T. (2023). Endocrine-related adverse events associated with targeted treatment and immune checkpoint blockage in hematological malignancies. Hematology in Clinical Practice. https://doi.org/10.5603/hcp.2023.0003

Vancouver

Bobrowicz M, Góralska M, Kusowska A, Skowrońska-Szcześniak A, Bednarczuk T. Endocrine-related adverse events associated with targeted treatment and immune checkpoint blockage in hematological malignancies. Hematology in Clinical Practice. 2023. doi:10.5603/hcp.2023.0003

BibTeX
@article{Bobrowicz2023,
  author = {Bobrowicz, Małgorzata and Góralska, Magdalena and Kusowska, Aleksandra and Skowrońska-Szcześniak, Anna and Bednarczuk, Tomasz},
  title = {Endocrine-related adverse events associated with targeted treatment and immune checkpoint blockage in hematological malignancies},
  journal = {Hematology in Clinical Practice},
  year = {2023},
  doi = {10.5603/hcp.2023.0003}
}
Kostenlos starten →